BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19414330)

  • 1. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket.
    Ohkura K; Kawaguchi Y; Watanabe Y; Masubuchi Y; Shinohara Y; Hori H
    Anticancer Res; 2009 Mar; 29(3):935-42. PubMed ID: 19414330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
    Williams PA; Cosme J; Vinkovic DM; Ward A; Angove HC; Day PJ; Vonrhein C; Tickle IJ; Jhoti H
    Science; 2004 Jul; 305(5684):683-6. PubMed ID: 15256616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450.
    Lee JY; Kang NS; Kang YK
    Biopolymers; 2012 Apr; 97(4):219-28. PubMed ID: 22113809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Human Drug-Metabolizing CYP3A4 with Small Inhibitory Molecules.
    Sevrioukova I
    Biochemistry; 2019 Feb; 58(7):930-939. PubMed ID: 30676743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Interactions, Ligand-Dependent Dynamics, and Stability of Cytochrome P4503A4 in Lipid Nanodiscs.
    Treuheit NA; Redhair M; Kwon H; McClary WD; Guttman M; Sumida JP; Atkins WM
    Biochemistry; 2016 Feb; 55(7):1058-69. PubMed ID: 26814638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational Response of N-Terminally Truncated Cytochrome P450 3A4 to Ligand Binding in Solution.
    Chuo SW; Liou SH; Wang LP; Britt RD; Poulos TL; Sevrioukova IF; Goodin DB
    Biochemistry; 2019 Sep; 58(37):3903-3910. PubMed ID: 31456404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining CYP3A4 structural responses to substrate binding. Raman spectroscopic studies of a nanodisc-incorporated mammalian cytochrome P450.
    Mak PJ; Denisov IG; Grinkova YV; Sligar SG; Kincaid JR
    J Am Chem Soc; 2011 Feb; 133(5):1357-66. PubMed ID: 21207936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
    Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of binding modes of ligands to multiple conformations of CYP3A4.
    Teixeira VH; Ribeiro V; Martel PJ
    Biochim Biophys Acta; 2010 Oct; 1804(10):2036-45. PubMed ID: 20601222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18422-7. PubMed ID: 20937904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.
    Moore CD; Shahrokh K; Sontum SF; Cheatham TE; Yost GS
    Biochemistry; 2010 Oct; 49(41):9011-9. PubMed ID: 20812728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for ligand promiscuity in cytochrome P450 3A4.
    Ekroos M; Sjögren T
    Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13682-7. PubMed ID: 16954191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing possible egress channels for multiple ligands in human CYP3A4: a molecular modeling study.
    Krishnamoorthy N; Gajendrarao P; Thangapandian S; Lee Y; Lee KW
    J Mol Model; 2010 Apr; 16(4):607-14. PubMed ID: 19727863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.
    Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W
    J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.
    Ducharme J; Sevrioukova IF; Thibodeaux CJ; Auclair K
    Biochemistry; 2021 Jul; 60(28):2259-2271. PubMed ID: 34196520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and dynamical basis of broad substrate specificity, catalytic mechanism, and inhibition of cytochrome P450 3A4.
    Park H; Lee S; Suh J
    J Am Chem Soc; 2005 Oct; 127(39):13634-42. PubMed ID: 16190729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin state.
    Harris DL; Park JY; Gruenke L; Waskell L
    Proteins; 2004 Jun; 55(4):895-914. PubMed ID: 15146488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anion-Dependent Stimulation of CYP3A4 Monooxygenase.
    Sevrioukova IF; Poulos TL
    Biochemistry; 2015 Jul; 54(26):4083-96. PubMed ID: 26066995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.